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Introduction {#sec005}
============

Despite significant policy efforts to fight unhealthy diets and physical inactivity (e.g. \[[@pone.0206703.ref001],[@pone.0206703.ref002]\]), overweight remains a crucial public health challenge for the US. According to the latest estimates, more than 64% of the US adult population has a body mass index (BMI) equal or above 25 kg/m^2^ \[[@pone.0206703.ref003]--[@pone.0206703.ref005]\]. About half of these individuals are obese (i.e. BMI ≥ 30 kg/m^2^). Recent analyses suggest that the increase in class I obesity (i.e. BMI between 30 and 35 kg/m^2^) may be occurring at smaller rate than prior to 2005 and that, overall, obesity rates may be stabilizing in both adults and youth \[[@pone.0206703.ref006]\]. Conversely, class III obesity (i.e. a BMI≥40 kg/m^2^) is rising twice as fast as overall obesity (i.e. BMI≥30 kg/m^2^) and shows no sign of plateauing \[[@pone.0206703.ref005],[@pone.0206703.ref007]\]. Furthermore, different analyses agree that the growth in obesity prevalence is not going to halt for the next ten to fifteen years \[[@pone.0206703.ref005],[@pone.0206703.ref008],[@pone.0206703.ref009]\].

The adverse healthcare consequences of obesity include, among the others, cardiovascular diseases, diabetes and cancers \[[@pone.0206703.ref010],[@pone.0206703.ref011]\]. All these diseases require heavy medicalisation and prompt a frequent use of healthcare services. Obese adults and children are more likely to be prescribed drugs \[[@pone.0206703.ref012],[@pone.0206703.ref013]\] and to use healthcare services, including diagnostic services \[[@pone.0206703.ref013]--[@pone.0206703.ref017]\], emergency room visits \[[@pone.0206703.ref013],[@pone.0206703.ref015],[@pone.0206703.ref016]\] and inpatient care \[[@pone.0206703.ref015],[@pone.0206703.ref017]\]. Moreover, when using a healthcare service, obese patients require more resource-intensive treatments \[[@pone.0206703.ref018],[@pone.0206703.ref019]\].

The associated impact on total healthcare expenditure is substantial. Finkelstein and colleagues \[[@pone.0206703.ref020]\] conclude that, between 1998 and 2006, obesity-attributable medical spending increased by 45.5% for inpatient care, 26.9% for non-inpatient care and 80.4% for drug expenditure. By using a different approach, Cawley and Meyerhoefer \[[@pone.0206703.ref021]\] argue that obesity may have a larger impact and, for some healthcare services, costs may be up to 9 times higher than previously calculated. Obese individuals with chronic physical disabilities would incur in almost double costs compared to obese individuals without chronic physical disabilities \[[@pone.0206703.ref017]\]. Wang \[[@pone.0206703.ref008]\] calculates that US medical costs associated with common diseases caused by obesity will increase by 48--66 billion USD per year by 2030.

Previous estimates were particularly useful for policy-makers because they justified the implementation of a broad set of preventive interventions to tackle obesity-related risk factors. However, from a healthcare service perspective, available evidence has important limitations. The most significant is that previous studies focus on obesity but do not specifically look at patients with severe obesity. This is particularly important, as patients with moderate and severe obesity have large differences in healthcare costs \[[@pone.0206703.ref019]\]. Second, available literature does not provide any insight about how healthcare services should adapt to meet future healthcare needs of obese people. This paper builds on the previous research by addressing both of these problems. In particular, this paper explores the contribution of increasing levels of BMI in shaping past and trends of use of a comprehensive set of healthcare services and associated expenditure in the US and project results to 2025.

Materials and methods {#sec006}
=====================

Methodological overview {#sec007}
-----------------------

Our analyses are primarily based on the Medical Expenditure Panel Survey (MEPS) \[[@pone.0206703.ref022]\], a dataset reporting information on use of healthcare services and associated expenditure. MEPS data was reweighted to match historical and projected national population statistics to 2015, 2020 and 2025 by using data from the National Health and Nutrition Examination Survey (NHANES) \[[@pone.0206703.ref023]\] and from the US Census Bureau (USCB) \[[@pone.0206703.ref024]\]. NHANES was used to calculate BMI prevalence rates and USCB provided information for population distribution by gender, age and ethnicity. The reweighting procedure was carried out on the basis of 384 small homogeneous population groups defined by gender, age group, ethnicity and BMI. A detailed definition of the categories can be found in the [S1 Appendix](#pone.0206703.s001){ref-type="supplementary-material"}.

Data {#sec008}
----

MEPS is an annual survey collecting data on demography, socio-economic status, healthcare utilization and expenditure for the US civilian non-institutionalized population. We used all the waves from 2000 to 2012 and pooled the data for the following six healthcare services: inpatient care (with and without surgery), office-based care, outpatient-care, drug prescription and home health care. Expenditure and charges are expressed in 2010 USD using event-specific product price indexes retrieved from the Office of the Actuary of the Centers for Medicare and Medicaid Services \[[@pone.0206703.ref025]\].

USCB provides the number of individuals in each population group by gender, age and ethnicity for each year between 2000 and 2025. Reweighting of MEPS data was also extended to data between 2000 and 2012 because discrepancies between MEPS and USCB in the size of the various population groups would have caused spurious inconsistencies between historical and projected trends. NHANES is a study designed to assess the health and the nutritional status of the US population. Our analysis uses all the available waves of NHANES between 1972 and 2012. Prevalence of BMI categories was reweighted on NHANES (rather than using prevalence rates calculated on MEPS) because NHANES covers a longer period (which allows more robust projections) and because NHANES provides the gold standard for BMI estimates in the US.

Analyses on MEPS {#sec009}
----------------

Use of healthcare services was modelled using a two-part model combining a logistic regression to model the probability of use of any specific healthcare service, combined with a generalized linear model (GLM), conditional on having positive access to the healthcare service, to model the average number of use of healthcare services \[[@pone.0206703.ref026],[@pone.0206703.ref027]\]. The expenditure specific to each healthcare service is calculated by multiplying the results of the previous two-step model for the average expenditure per access calculated, again, with a GLM model. The Akaike information criterion \[[@pone.0206703.ref028],[@pone.0206703.ref029]\] approach was used to select the best fitting combination of link and distribution families in all the GLMs. All the GLMs (but those on use of inpatient services) were calculated by fitting a gamma (Poisson) distribution and a log link. The set of explanatory variables included: gender, age group, ethnicity, level of education, family income, type of insurance coverage, marital status, region of residence, BMI category and year. This approach was shown to be the most suitable to model use of healthcare services and healthcare expenditure \[[@pone.0206703.ref026]\]. The projections of the use of healthcare services and their associated expenditure were estimated on the fitted models by setting the value of the variables as follows: gender, age group, ethnicity and BMI category were set at the values calculated on NHANES and USCB; all the other covariates, with the exception of the variable year, were set at their values as in MEPS for the period 2000--2012 and at the value they had in 2012 for the projections; the variable year was set at the relevant year (e.g. 2008, 2015, etc.) to account for any underlying trend (e.g. changes in clinical practice).

Calculation of the weights {#sec010}
--------------------------

For each year, resampling weights are calculated in two steps. In a first step USCB data was used to calculate the relative prevalence of each population group defined by gender, age-group and ethnicity. AS USCB provides both historical and projected population estimates, no further manipulation was necessary. In a second step, NHANES data was used to further split these groups by six levels of BMI for adults \[[@pone.0206703.ref004]\] and three for children \[[@pone.0206703.ref030]\]. Waves between 2000 and 2012 provided the prevalence of each population group by BMI level for the relevant period. Projected prevalence rates were instead calculated by using a quantile regression (QR) approach on all the waves between 1972 and 2012. QR was selected because it is particularly efficient when individual quantiles in the distribution of an outcome (i.e. BMI) behave differently along a given dimension (i.e. time). Additionally, QR does not impose any constraint on the future distribution of the outcome variable allowing for higher flexibility in projections and for a non-linear extrapolation of prevalence rates. Thus, it can take into account slowdowns or rapidly increasing trends in specific population sub-groups. All the models include as explanatory variables the same set of variables used on MEPS; in addition the models include a squared version of the variable year as well as interaction terms between year and age group and between gender and education level/socio-economic status (additional information can be found in the [S1 Appendix](#pone.0206703.s001){ref-type="supplementary-material"}). BMI projections were estimated by setting the time period to the forecasted year (e.g. 2020) while maintaining all the other covariates at the most recent year for which data is available.

Results {#sec011}
=======

The US population in 2000 and in 2025: Epidemiologic and socio-demographic developments {#sec012}
---------------------------------------------------------------------------------------

Between 2000 and 2025, the US population will go through significant epidemiologic and socio-demographic changes ([Table 1](#pone.0206703.t001){ref-type="table"}). 12.7% of US population was aged 65 or more in 2000. This percentage will increase by about 50% (+5.8% in absolute terms) and people aged 65 or more will become 18.5% of the US population in 2025. The prevalence of white non-hispanic people is also gradually decreasing while the prevalence rate of Hispanics and Asians is expected to grow by more than 50% between 2000 and 2025. Changes in the prevalence of overweight and obesity are also considerable. Almost 64% of the US population will be either overweight or obese in 2025, compared to about 54% in 2000. Severe obesity (i.e. class III obesity) shows particularly high growth rates, rising from about 3.1% of the population in 2000 to 4.5% in 2012 (i.e. +44%), to 6.1% in 2025 (i.e. +35% compared to 2012).

10.1371/journal.pone.0206703.t001

###### Key socio-demographic characteristics; prevalence rate in the US population, 2000--2025.
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                         historic data   projections                                       
  ---------------------- --------------- ------------- -------- -------- -------- -------- --------
  Population (million)   275.31          285.27        295.01   304.76   312.27   324.93   337.81
  Gender                                                                                   
  Males                  0.489           0.489         0.489    0.489    0.489    0.489    0.488
  Females                0.511           0.511         0.511    0.511    0.511    0.511    0.512
  Age                                                                                      
  0--44                  0.651           0.630         0.610    0.597    0.591    0.586    0.582
  45--64                 0.222           0.244         0.260    0.265    0.262    0.249    0.232
  65+                    0.127           0.126         0.130    0.138    0.147    0.165    0.185
  Ethnicity                                                                                
  White non-Hispanic     0.714           0.697         0.681    0.666    0.655    0.638    0.620
  Black                  0.128           0.130         0.132    0.134    0.136    0.138    0.139
  Hispanic               0.108           0.118         0.128    0.137    0.144    0.155    0.166
  Others                 0.050           0.054         0.058    0.062    0.065    0.070    0.075
  BMI category^a^                                                                          
  Underweight            0.016           0.014         0.013    0.010    0.009    0.008    0.010
  Normal-weight          0.448           0.418         0.398    0.397    0.387    0.369    0.354
  Pre-obesity            0.302           0.304         0.301    0.303    0.304    0.309    0.325
  Class I obesity        0.147           0.163         0.174    0.180    0.187    0.193    0.181
  Class II obesity       0.055           0.062         0.069    0.064    0.064    0.065    0.069
  Class III obesity      0.031           0.039         0.045    0.045    0.049    0.056    0.061
  Insurance coverage                                                                       
  public-only            0.726           0.697         0.663    0.644    0.681    0.673    0.664
  Private                0.157           0.180         0.203    0.229    0.192    0.200    0.209
  out-of-pocket          0.117           0.123         0.134    0.127    0.127    0.127    0.126

^a^ BMI (Body Mass Index) categories are defined according to WHO thresholds (WHO, 2016) for adults and Cole et al. 2000 for children and teenagers

Use of healthcare services and expenditure at different levels of obesity {#sec013}
-------------------------------------------------------------------------

Throughout the studied period, the rate of drug prescriptions for obese people is, on average, 2.4 times higher than for normal-weight people ([Table 2](#pone.0206703.t002){ref-type="table"}). However, individuals in class III obesity show a rate of drug prescription which is, on average 3.6 times higher than normal-weight individuals. Similar patterns can be identified for all the other types of healthcare services included in the study. For instance, compared to normal-weight people, individuals in class III obesity are respectively 2.1, 2.7 and 4.5 times more likely to be admitted to a hospital, to undergo surgery or to use home healthcare services.

10.1371/journal.pone.0206703.t002

###### Healthcare service use and (standard error) per 1000 persons by year, category of service and BMI; US population 2000--2025.
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  -----------------------------------------------------------------------------------------------------------------------------------
  BMI[^a^](#t002fn002){ref-type="table-fn"}   2000           2012   2015    2020   2025                                         
  ------------------------------------------- -------------- ------ ------- ------ ------- ------ ------- ------ ------- ------ -----
  Prescriptions                               \[18.5--25\]   6081   156     7223   202     7558   258     8092   331     8875   434

  \[25--30\]                                  9539           217    11285   263    11647   332    12081   415    12485   516    

  \[30--35\]                                  11693          261    13921   309    14352   388    15542   505    15884   636    

  \[35--40\]                                  17206          416    20389   497    21692   620    23197   786    25698   1018   

  \[40+                                       20723          541    25215   650    26721   795    30623   1027   35382   1355   

  Inpatient care\                             \[18.5--25\]   215    6       198    6       191    7       182    8       175    9
  (no surgery)                                                                                                                  

  \[25--30\]                                  242            7      224     6      215     7      205     8      195     9      

  \[30--35\]                                  282            8      261     8      251     9      244     10     235     11     

  \[35--40\]                                  344            11     322     10     316     11     312     13     312     15     

  \[40+                                       426            1      406     15     397     16     396     18     397     20     

  Inpatient care (surgery)                    \[18.5--25\]   86     4       77     4       74     5       70     5       66     6

  \[25--30\]                                  111            5      100     5      97      6      90      6      83      7      

  \[30--35\]                                  128            6      115     6      111     6      106     7      100     8      

  \[35--40\]                                  174            9      159     8      160     9      157     11     157     12     

  \[40+                                       211            11     199     11     199     13     201     15     205     18     

  Office-based care                           \[18.5--25\]   4219   103     4308   108     4329   127     4348   150     4403   180

  \[25--30\]                                  5181           119    5278    122    5235    143    5144    169    5058    198    

  \[30--35\]                                  5793           134    5881    140    5847    163    5917    196    5788    232    

  \[35--40\]                                  7172           180    7308    199    7430    232    7423    273    7672    328    

  \[40+                                       7913           235    8195    249    8318    281    8761    331    9181    393    

  Outpatient care                             \[18.5--25\]   363    27      266    22      249    26      249    26      196    31

  \[25--30\]                                  564            36     411     29     382     35     382     35     273     37     

  \[30--35\]                                  600            41     439     31     405     36     405     36     299     39     

  \[35--40\]                                  958            84     714     76     699     89     699     89     550     91     

  \[40+                                       1013           81     774     67     751     78     751     78     687     93     

  Home healthcare                             \[18.5--25\]   79     15      75     14      82     22      82     26      89     33

  \[25--30\]                                  103            16     97      15     105     23     100     28     95      32     

  \[30--35\]                                  99             16     93      15     102     24     111     30     115     39     

  \[35--40\]                                  167            27     170     28     194     42     221     55     261     74     

  \[40+                                       273            44     295     49     348     75     408     97     506     130    
  -----------------------------------------------------------------------------------------------------------------------------------

The table reports the number of times that a given healthcare service was used per 1000 persons; prescriptions refers to the number of drug prescriptions; SE is standard error

^a^ BMI (Body Mass Index) categories are defined according to WHO thresholds (WHO 2016) for adults and Cole et al. 2000 for children and teenagers.

Obese and severe obese individuals use a significantly higher share of healthcare resources. Normal-weight and overweight people show decreasing or substantially stable trends of use of healthcare services (drug prescriptions excluded). The opposite is true for obese people and, in particular, individuals in class III obesity. In this group, for example, use of home healthcare services is expected to increase from 273 (confidence interval, ci: 187--359) episodes per thousand people in 2000 to 295 (ci: 199--391) episodes per thousand people in 2012 (+8%) to 506 (ci: 251--761) episodes per thousand people in 2025 (+72% compared to 2012). Similarly, the average number of drug prescriptions increased from an average of 20.7 (ci: 19.7--21.8) prescriptions per severe obese patient in 2000 to 25.2 (ci: 23.9--26.5) in 2012 (+22%) to 35.4 (ci: 32.7--38.0) in 2025 (+40% compared to 2012).

As shown in [Table 3](#pone.0206703.t003){ref-type="table"}, obesity is also associated with higher healthcare service-specific expenditure and total expenditure (calculated as the sum of the expenditure for all the healthcare services used by a patient). For example, healthcare expenditure for drug prescriptions and inpatient care with or without surgery is twice as high in obese patients as it is in normal-weight individuals. Similarly, total healthcare expenditure for individuals in class II and class III obesity is, respectively, 2.2 and 2.5 times higher than in normal-weight individuals.

10.1371/journal.pone.0206703.t003

###### Healthcare expenditure and (standard error) per capita by year, category of service and BMI; US population 2000--2025.
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  BMI[^a^](#t003fn002){ref-type="table-fn"}   2000           2012   2015    2020   2025                                         
  ------------------------------------------- -------------- ------ ------- ------ ------- ------ ------- ------ ------- ------ -----
  Prescriptions                               \[18.5--25\]   383    22      641    59      758    88      993    147     1334   237
  \[25--30\]                                  601            34     999     58     1166    92     1480    159    1877    250    
  \[30--35\]                                  717            45     1206    65     1406    103    1862    184    2304    288    
  \[35--40\]                                  1004           53     1677    96     2016    151    2629    269    3529    446    
  \[40+                                       1202           65     2054    121    2463    187    3451    342    4855    585    
  Inpatient care (no surgery)                 \[18.5--25\]   834    61      939    71      1026   88      1183   115     1395   152
  \[25--30\]                                  1145           75     1294    85     1410    106    1604    135    1820    170    
  \[30--35\]                                  1278           90     1458    97     1594    119    1883    154    2123    196    
  \[35--40\]                                  1819           136    2085    151    2352    186    2794    241    3367    317    
  \[40+                                       2273           181    2680    218    3024    268    3734    349    4670    468    
  Inpatient care (surgery)                    \[18.5--25\]   735    54      801    61      866    77      961    96      1092   123
  \[25--30\]                                  1033           67     1130    76     1218    96     1330    117    1444    142    
  \[30--35\]                                  1142           78     1255    87     1354    107    1537    134    1663    163    
  \[35--40\]                                  1627           122    1804    135    2020    167    2316    207    2681    260    
  \[40+                                       1977           165    2260    192    2523    234    3001    291    3618    372    
  Office-based care                           \[18.5--25\]   520    19      886    35      1047   47      1385   70      1848   106
  \[25--30\]                                  674            24     1145    40     1341    53     1747    79     2282    115    
  \[30--35\]                                  758            28     1285    51     1514    66     2034    98     2611    140    
  \[35--40\]                                  957            37     1620    67     1944    88     2548    128    3457    189    
  \[40+                                       1028           54     1773    95     2123    119    2945    170    4039    246    
  Outpatient care                             \[18.5--25\]   338    31      328    32      334    38      334    38      373    56
  \[25--30\]                                  529            41     514     44     520     52     520     52     556     73     
  \[30--35\]                                  569            47     561     48     569     56     569     56     604     77     
  \[35--40\]                                  922            94     899     107    927     121    927     121    1005    154    
  \[40+                                       942            94     923     99     950     111    950     111    1142    157    
  Home healthcare                             \[18.5--25\]   79     20      100    25      124    43      151    60      200    86
  \[25--30\]                                  101            21     127     26     155     45     181     61     209     80     
  \[30--35\]                                  105            23     132     28     165     49     219     73     278     104    
  \[35--40\]                                  149            32     207     44     267     73     374     111    537     172    
  \[40+                                       244            52     354     77     474     132    681     194    1039    301    
  Total healthcare expenditure                \[18.5--25\]   2890   16      3695   20      4156   27      5024   39      6243   57
  \[25--30\]                                  4083           20     5210    24     5810    32     6879    44     8188    62     
  \[30--35\]                                  4568           23     5896    27     6603    36     8139    51     9583    72     
  \[35--40\]                                  6479           36     8292    43     9527    56     11613   78     14576   113    
  \[40+                                       7666           47     10043   59     11557   76     14858   106    19363   156    

The table reports the average healthcare expenditure per capita; prescriptions refers to the average expenditure for drug prescriptions; SE is standard error

^a^ BMI (Body Mass Index) categories are defined according to WHO thresholds (WHO 2016) for adults and Cole et al. 2000 for children and teenagers.

The expenditure of the majority of healthcare services is expected to grow by about 1.5 to 3.5 times in the period 2000--2025 with about a third of this increase taking place between 2000 and 2012. Healthcare expenditure in obese individuals tends to grow more than in normal-weight individuals. For example, the average expenditure per episode of inpatient care with surgery for a normal-weight patient increases from 735 (ci: 629--841) USD in 2000 to 1,092 (ci: 851--1,333) USD in 2025 (i.e. +49%) while, in the same period, the average expenditure for a class III obese patient increases from 1,977 (ci: 1,654--2,300) USD to 3,618 (ci: 2889--4347) USD (i.e. +83%). Average total healthcare expenditure in 2025 will be more than twice as high as in 2000. In 2025, normal-weight individuals and individuals in class II and class III obesity show an average total healthcare expenditure which is respectively 69%, 76% and 93% higher than in 2012.

The effect of obesity on the use of healthcare services at the population level {#sec014}
-------------------------------------------------------------------------------

Figs [1](#pone.0206703.g001){ref-type="fig"} and [2](#pone.0206703.g002){ref-type="fig"} show the expected change in use of healthcare services and healthcare expenditure at the population level by BMI category, taking 2000 as the base year. These two figures are calculated by taking into account changes in use of healthcare services and expenditure at the individual level as presented in Tables [2](#pone.0206703.t002){ref-type="table"} and [3](#pone.0206703.t003){ref-type="table"} and the number of individuals in each BMI category ([Table 1](#pone.0206703.t001){ref-type="table"}). At the population level, use of all healthcare services, but outpatient care, is expected to increase ([Fig 1](#pone.0206703.g001){ref-type="fig"} and additional results in the [S1 Fig](#pone.0206703.s002){ref-type="supplementary-material"}). Drug prescriptions and use of home healthcare services are the healthcare services increasing the most. Inpatient care with or without surgery is projected to increase, but at a smaller rate.

![Change in use of healthcare services (%) by category of service and BMI; US population 2000--2025.\
Note: continuous lines represent historical trends; dotted lines represent projections; BMI (Body Mass Index) categories are defined according to WHO thresholds (WHO 2016) for adults and Cole et al. 2000 for children and teenagers; 2000 is base year equal to 100; additional results in the [S1 Fig](#pone.0206703.s002){ref-type="supplementary-material"}.](pone.0206703.g001){#pone.0206703.g001}

![Change in healthcare expenditure (%) by category of service and BMI; US population 2000--2025.\
Note: continuous lines represent historical trends; dotted lines represent projections; BMI (Body Mass Index) categories are defined according to WHO thresholds (WHO 2016) for adults and Cole et al. 2000 for children and teenagers; 2000 is base year equal to 100; additional results in the [S2 Fig](#pone.0206703.s003){ref-type="supplementary-material"}.](pone.0206703.g002){#pone.0206703.g002}

After scaling-up results presented in [Table 2](#pone.0206703.t002){ref-type="table"} to the population level (i.e. by taking into account the number of individuals in different BMI categories and its evolution over time), normal-weight and overweight individuals show decreasing or stable trends in use of many healthcare services (e.g. outpatient care and inpatient care with or without surgery). Trends in use of healthcare services for individuals in class I obesity showed a sustained increase between 2000 and 2012. Such increase is projected to continue, but at a smaller rate, between 2012 and 2020 and to stabilize (i.e. drug prescriptions and home healthcare services) or even reverse (i.e. all the other healthcare services) after 2020. Conversely, use of healthcare services for individuals in class II and class III obesity increases consistently. This pattern is particularly clear in the case of outpatient care services. In fact, total number of outpatient visits is expected to decrease for all the BMI categories with the exception of individuals in class III obesity whose total number is expected to increase by 60% between 2000 and 2025.

At the population level, real-term total healthcare expenditure (i.e. after adjusting for inflation) increased by about 50% between 2000 and 2012 and is expected to increase by a further 91% between 2012 and 2025. Total healthcare expenditure is expected to increase more quickly in the obese population. For example, total expenditure for individuals in class III obesity increased by about 110% between 2000 and 2012 and is projected to increase by about 190% between 2012 and 2025.

Healthcare service-specific expenditure is also expected to increase. Drug prescription and office based care show the greatest growth (i.e. about 4 times between 2000 and 2025), while outpatient care and inpatient care with surgery show the smallest increase (i.e. 1.5--2 times). Expenditure in class I to class III obese patients consistently grows more quickly than in normal-weight and overweight individuals. Real-term expenditure for outpatient care in normal-weight individuals is projected to remain virtually stable throughout the studied period.

Discussion {#sec015}
==========

Obesity has been an important factor in determining recent trends of use of healthcare services and associated expenditure. Our analyses suggest that obesity will also play a significant role in the next decade. Only 1 in 3 people living in the US will not be overweight or obese by 2025 while the number of individuals in class III obesity is expected to grow to 20.5 million people in 2025.

Per capita use of many healthcare services, including inpatient care with and without surgery and outpatient care, is generally decreasing over time for all the individuals independently from their level of BMI. Simultaneously, the number of drug prescriptions and use of home healthcare services has steadily increased suggesting that these healthcare services may have allowed a sharp reduction in the number of hospitalizations. Conversely, the average expenditure per episode has been increasing.

By scaling up these trends at the population levels, our analyses suggest that the US should expect a significant increase in the total number of episodes of care and its associated expenditure. Two crucial drivers of such increase are the growth in the obese population, severely obese individuals in particular, and a higher average expenditure per episode of care. Conversely, decreasing trends in average use of some healthcare services and a levelling-off of the expenditure for overweight individuals, whose expenditure is converging towards the levels of normal-weight individuals help prevent a more significant increase in total healthcare expenditure.

Policy implications {#sec016}
-------------------

From a policy perspective a crucial issue is how decision makers can respond to these trends. A sustained emphasis on policies to encourage healthier lifestyles may contribute to further curb obesity rates. Actions to prevent obesity were shown to save up to 8.3 USD in healthcare expenditure for each US resident \[[@pone.0206703.ref026]\]. About two thirds of these savings would derive from decreased expenditure for inpatient care, followed by a 30% decrease in expenditure for drug prescriptions. However, while prevention has the potential to play a significant role in curbing rising healthcare expenditure, it is unlikely that prevention can reverse such trends on its own. Our analyses suggest that inpatient services are increasingly substituted by pharmaceutical prescriptions and, possibly, by a wider use of other healthcare services. The expenditure for these healthcare services is lower compared to the expenditure for inpatient care. Moreover, there is evidence that substituting inpatient care with drug prescriptions \[[@pone.0206703.ref031]\] and ambulatory care \[[@pone.0206703.ref032]\] may reduce total healthcare expenditure without affecting the health of the population. Policy makers, therefore, should be encouraged to put in place new actions aimed at supporting and reinforcing substitution of resource-intensive healthcare services with more efficient alternatives.

Another crucial challenge is adapting healthcare services to meet a changing population with new healthcare needs. Use of healthcare by class II and class III obese people is projected to grow significantly and, inevitably, healthcare facilities will have to adapt to treat a higher number of severely obese patients. This will require investments on designing suitable facilities and space, on proper equipment and on training and implementing new clinical protocols \[[@pone.0206703.ref033]\]. Some of these changes, particularly those concerning structural renovation and removal of architectural barriers, require substantial time and planning before their implementation. It is therefore crucial that healthcare services start working on required arrangements in the short term.

Comparison of the results from this study with previous attempts {#sec017}
----------------------------------------------------------------

Our results compare favourably to previous research in the field. Two previous studies \[[@pone.0206703.ref008],[@pone.0206703.ref034]\] projected that about 45--50% of the US adult population would be obese in 2030. Finkelstein and colleagues \[[@pone.0206703.ref009]\] instead predict that, respectively, 42% and 11% of the US would be obese and severely obese in 2030. Our analyses conclude that about 36% of the population aged 15 and over will be obese and 7.6% will be severely obese by 2025. Two main reasons help explain why we report slightly lower obesity rates. First, our projections use a shorter timeframe, i.e. 2025 as opposed to 2030. Second, our projections are based on more recent data and reflect a recent plateauing of obesity which emerged after the publication of previous studies.

Some previous studies have also analysed historical trends in use of healthcare services and expenditure by level of BMI. In line with the literature (e.g. \[[@pone.0206703.ref015],[@pone.0206703.ref019]\]) our analyses conclude that patients in different classes of obesity have a use of healthcare services which is between 2 and 3.5 times higher than in normal-weight patients. Few studies have also attempted to project obesity-related healthcare costs. For example, Wang et al. \[[@pone.0206703.ref034]\] conclude that expenditure attributable to obesity is expected to roughly double every decade between 2000 and 2030. Despite differences in the scope of the two studies, results of our analysis seem to suggest that we should expect a lower increase in obesity-attributable expenditure, mainly due to lower obesity rates than forecasted by the previous study.

Study limitations and strengths {#sec018}
-------------------------------

A number of limitations should be noted. The most important is that MEPS data report lower estimations of healthcare expenditure compared to estimates based on the National Health Expenditure Accounts (NHEA) \[[@pone.0206703.ref035]\]. The main reason is that NHEA includes spending for people residing in institutions while MEPS does not. NHEA also includes expenses for services that are not included in MEPS as, for example, over the counter medications. Finally, MEPS is largely based on self-reported information and recall errors or imperfect understanding of questions may not correctly reflect reality. MEPS addresses this issue by supplementing individual-reported information with administrative data. However, it cannot be completely excluded that, in some cases (e.g. individuals denying the permission to contact providers), the procedure is not fully successful. Because of all these limitations, presented estimates are likely to be conservative and increase in healthcare expenditure may be higher.

A second factor may affect our analyses by making our results more conservative. Our analysis aims to understand the specific contribution of obesity in shaping future healthcare needs. To better appreciate the effect of BMI, we decided to maintain constant all the other socio-economic characteristics of the US population. Hence, our projections assume that historical trends will continue into the future with no disruptive modification in how healthcare services are delivered.

A third factor could influence our findings. Obese individuals have a lower life expectancy than normal-weight individuals \[[@pone.0206703.ref036]\] and, in principle, this could affect our population-level projections. However, USCB projections take into account past trends and current levels of health-related conditions including those caused by obesity \[[@pone.0206703.ref037]\]. Therefore, our projections should be sufficiently robust to capture any potential future reduction in population size due to higher levels of BMI.

This study enriches the literature in a number of aspects. First, this study explores future trends of use of a wide-ranging set of healthcare services including: inpatient care with surgery, inpatient care without surgery, office-based care, outpatient-care, drug prescription and home healthcare. Second, this study does not exclusively focus on total expenditure but investigates the contribution of each healthcare service and its associated expenditure. Third, this paper pinpoints the effect of the different classes of BMI to allow a comparison with other key drivers influencing future levels of healthcare expenditure. Therefore, compared to previous studies, this paper provides policy-makers unique evidence about expected changes in the demand for specific healthcare services. Finally, from a methodological point of view, results of this paper demonstrate that future analyses projecting healthcare expenditure should account for the effects of key epidemiological trends as increasing levels of obesity. Otherwise, results may significantly underestimate the real change in healthcare expenditure.

Conclusions {#sec019}
===========

This study shows that, between 2000 and 2025, the US population will go through significant epidemiological and socio-demographic changes. Increasing levels of obesity will be a key driver underlying future rises in use of healthcare services and associated expenditure. In particular, obesity will counteract other factors (e.g. changes in delivery of healthcare due to technological innovation and medical advances) that, otherwise, would produce a decrease in the use of inpatient care and other healthcare services. For example, healthcare expenditure for patients with class III obesity will grow from 6% of total healthcare expenditure in 2000 to about 14% in 2025. If no intervention to curb such trends is put in place, total healthcare expenditure per capita in 2025 could be almost three times what it was in 2000.
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